-
Impact of Short-Term Liraglutide Therapy on Non-Invasive Markers of Liver Fibrosis in Patients with MASLD
-
The Long-Term Impact of Preterm Birth on Metabolic Bone Profile and Bone Mineral Density in Childhood
-
Prediagnostic Plasma Metabolomic Profiles Using NMR for Exfoliation Glaucoma Among US Health Professionals
-
Human Metabolism of Sirolimus Revisited
Journal Description
Metabolites
Metabolites
is an international, peer-reviewed, open access journal of metabolism and metabolomics, published monthly online by MDPI.
- Open Access— free for readers, with article processing charges (APC) paid by authors or their institutions.
- High Visibility: indexed within Scopus, SCIE (Web of Science), PubMed, PMC, Embase, CAPlus / SciFinder, and other databases.
- Journal Rank: JCR - Q2 (Biochemistry and Molecular Biology) / CiteScore - Q2 (Endocrinology, Diabetes and Metabolism)
- Rapid Publication: manuscripts are peer-reviewed and a first decision is provided to authors approximately 14.4 days after submission; acceptance to publication is undertaken in 3.6 days (median values for papers published in this journal in the first half of 2025).
- Recognition of Reviewers: reviewers who provide timely, thorough peer-review reports receive vouchers entitling them to a discount on the APC of their next publication in any MDPI journal, in appreciation of the work done.
Impact Factor:
3.7 (2024);
5-Year Impact Factor:
4.1 (2024)
Latest Articles
Association of Gla-Rich Protein (GRP) with Inflammatory Markers in Critically Ill Patients: A Cross-Sectional Observational Study
Metabolites 2025, 15(9), 611; https://doi.org/10.3390/metabo15090611 (registering DOI) - 13 Sep 2025
Abstract
Objectives: Gla-rich protein (GRP), a vitamin K-dependent protein, has been increasingly recognized for its dual role in modulating inflammation and inhibiting pathological calcification. Despite its emerging importance in chronic conditions, limited evidence exists regarding its behavior during acute critical illness. This study aimed
[...] Read more.
Objectives: Gla-rich protein (GRP), a vitamin K-dependent protein, has been increasingly recognized for its dual role in modulating inflammation and inhibiting pathological calcification. Despite its emerging importance in chronic conditions, limited evidence exists regarding its behavior during acute critical illness. This study aimed to investigate the association between GRP, systemic inflammatory markers, oxidative stress (via total thiol oxidation-reduction ratio, TORR), and calcium metabolism in critically ill patients. Materials and Methods: This cross-sectional observational study included 93 critically ill patients admitted to the intensive care unit (ICU) and 60 age- and sex-matched non-critically ill volunteers. Serum GRP levels were measured using ELISA. Other biomarkers including TORR, C-reactive protein (CRP), procalcitonin (PCT), white blood cell count (WBC), immature granulocytes (IGs), and serum calcium were also analyzed. Pearson’s correlation, multivariate linear regression, and ROC analysis were performed to assess the relationships among GRP and biochemical markers, as well as their capacity to differentiate ICU patients from controls. Results: GRP, TORR, CRP, PCT, WBC, IGs, and ferritin levels were significantly elevated in ICU patients compared to the control group, whereas serum calcium levels were markedly reduced (all p < 0.05). GRP levels demonstrated moderate positive correlations with WBC (r = 0.47), neutrophils (r = 0.51), TORR (r = 0.42), CRP (r = 0.30), and IGs (r = 0.46), and a strong negative correlation with calcium (r = −0.63). In multivariate regression, TORR, CRP, WBC, IGs, PCT, and calcium levels showed significant correlations with GRP levels in univariate analysis. ROC analysis revealed that CRP had the highest discriminatory power (AUC = 0.88; 95% CI: 0.82–0.94), followed by TORR (AUC = 0.79; 95% CI: 0.71–0.86), GRP (AUC = 0.76; 95% CI: 0.68–0.84), and IGs (AUC = 0.77; 95% CI: 0.69–0.85), for distinguishing ICU patients from non-critically ill individuals. Conclusions: Our findings demonstrated that GRP is significantly associated with systemic inflammation, oxidative stress, and calcium metabolism disturbances in critically ill patients. The combined evaluation of GRP and TORR may enhance the understanding of inflammatory and oxidative mechanisms in acute critical illness. Although this study did not assess patient outcomes, these biomarkers could serve as promising candidates for future prognostic research in ICU settings.
Full article
(This article belongs to the Special Issue Metabolite Profiles in Inflammatory Diseases)
►
Show Figures
Open AccessArticle
SnRK-PP2C-PYL Gene Families in Citrus sinensis: Genomic Characterization and Regulatory Roles in Carotenoid Metabolism
by
Pengjun Lu, Zhenting Shi, Tao Liu, Jianqiu Ji, Jing Li, Wentao Li and Chongbo Sun
Metabolites 2025, 15(9), 610; https://doi.org/10.3390/metabo15090610 - 12 Sep 2025
Abstract
Background/Objectives: Carotenoids in citrus are vital nutritional compounds and precursors of the stress hormone abscisic acid (ABA). SNF1-related kinases (SnRKs)—key regulators of plant stress signaling that phosphorylate is targeting proteins for post-transcriptional regulation—mediate ABA signaling through its subfamily SnRK2-phosphatase type-2C (PP2C)-PYR1-LIKE (PYL)
[...] Read more.
Background/Objectives: Carotenoids in citrus are vital nutritional compounds and precursors of the stress hormone abscisic acid (ABA). SNF1-related kinases (SnRKs)—key regulators of plant stress signaling that phosphorylate is targeting proteins for post-transcriptional regulation—mediate ABA signaling through its subfamily SnRK2-phosphatase type-2C (PP2C)-PYR1-LIKE (PYL) cascades. This study aims to identify the SnRK-PP2C-PYL family members and decipher their underlying post-transcriptional regulatory mechanisms which control carotenoid metabolism in Citrus sinensis for improved nutrition and stress resilience. Methods: SnRK, PP2C, and PYL were identified by integrated HMMER-blastp-CDD pipeline in the Citrus genome. Using two carotenoid-divergent cultivars, ‘Newhall’ (yellow) and ‘Cara Cara’ (red, hyperaccumulating linear carotenoids), we conducted spatiotemporal expression profiling and integrated transcriptomic and metabolomic data via Weighted Gene Co-expression Network Analysis (WGCNA) to identify modules correlated with accumulation. Results: We identified 26 CsSnRKs (1 SnRK1, 7 SnRK2, 18 SnRK3), 57 CsPP2Cs, and 7 CsPYLs in Citrus sinensis. Despite a >26-fold difference in linear carotenoids, structural gene expression was similar among cultivars, strongly implicating post-transcriptional control. WGCNA identified a key turquoise module highly correlated with linear carotenoid content. This module contained phosphorylation-related genes (CsSnRK1/3.5/3.6/3.16, CsPP2C14/15/33/35/38/40/43/56, and CsPYL6), biosynthetic genes (CsPSY1, CsZISO, and CsZDS), and candidate transcription factors. Network analysis predicted that CsSnRKs, CsPP2Cs, and CsPYLs regulate phytoene-derived carotenoid biosynthesis. Conclusions: We propose a novel phosphorylation-mediated post-transcriptional regulatory network in carotenoid accumulation. This mechanism bridges ABA signaling and metabolic adaptation, providing crucial molecular targets for engineering nutrient-dense and climate-resilient citrus varieties.
Full article
(This article belongs to the Section Plant Metabolism)
►▼
Show Figures

Figure 1
Open AccessArticle
Comparison of the Metabolic and Flavor Characteristics of the Egg Yolks of BIAN Chicken and Hy-Line Brown Chicken Using LC-MS and GC × GC-TOF MS Techniques
by
Bochi Zhang, Xianyi Song, Kaige Li, Kai Zhang, Rui Zhao, Chunlei Yang and Liying Du
Metabolites 2025, 15(9), 609; https://doi.org/10.3390/metabo15090609 - 12 Sep 2025
Abstract
Objectives: This study systematically compared the differences in egg quality between the BIAN chicken, an indigenous breed of Shanxi Province, and the Hy-Line Brown, a commercial breed, through the integration of non-targeted metabolomics and volatile flavoromics methods. Methods: A total of 675 metabolites
[...] Read more.
Objectives: This study systematically compared the differences in egg quality between the BIAN chicken, an indigenous breed of Shanxi Province, and the Hy-Line Brown, a commercial breed, through the integration of non-targeted metabolomics and volatile flavoromics methods. Methods: A total of 675 metabolites and 84 volatile flavor compounds were identified in eggs from 300-day-old laying hens using LC-MS and GC × GC-TOF MS techniques. Results: BIAN chicken eggs exhibited notable advantages in flavor quality. The relative odor activity value (ROAV) of 1-octen-3-ol, a key flavor component, was 27.01 in BIAN compared with 13.46 in Hy-Line Brown, contributing to the characteristic mushroom aroma of BIAN eggs. Furthermore, the levels of heptaldehyde, 2-pentylfuran, and styrene in BIAN chicken eggs were significantly elevated, contributing to its characteristic flavor profile. Metabolomic analysis identified 40 breed-specific metabolites in BIAN chicken, with 21 up-regulated and 19 down-regulated. These metabolites were primarily involved in biological processes such as α-linolenic acid metabolism, cholesterol metabolism, and unsaturated fatty acid biosynthesis, highlighting the distinctive lipid metabolism regulation in BIAN chicken. Sensory evaluation based on relative odor activity values (ROAV) demonstrated that BIAN chicken eggs exhibited enhanced sweet, fruity, herbal, and citrus aromas, which correlated with the enriched lipid metabolism pathways. Conclusions: This study elucidates the molecular basis of distinctive egg quality characteristics in local chicken breeds, offering a scientific rationale for the conservation and utilization of indigenous breeds and the documentation of their unique metabolic and sensory properties. Furthermore, it furnishes a theoretical framework for understanding breed-specific flavor development and provides baseline data for future genetic selection and nutritional intervention strategies.
Full article
(This article belongs to the Special Issue Metabolomics in Food Science and Nutrition Using GC-MS)
►▼
Show Figures

Figure 1
Open AccessArticle
Metabolomics and Cytokine Signatures in COVID-19: Uncovering Immunometabolism in Pathogenesis
by
Mohammad Mehdi Banoei, Abdulrazagh Hashemi Shahraki, Kayo Santos, Gregory Holt and Mehdi Mirsaeidi
Metabolites 2025, 15(9), 608; https://doi.org/10.3390/metabo15090608 - 11 Sep 2025
Abstract
Background: This study aimed to analyze metabolic changes in blood samples from patients with confirmed COVID-19 to explore the correlation between metabolomics and cytokines in survivors and non-survivors of SARS-CoV-2 infection. Understanding the complex biochemical and immunometabolic mechanisms underlying SARS-CoV-2 infection is essential
[...] Read more.
Background: This study aimed to analyze metabolic changes in blood samples from patients with confirmed COVID-19 to explore the correlation between metabolomics and cytokines in survivors and non-survivors of SARS-CoV-2 infection. Understanding the complex biochemical and immunometabolic mechanisms underlying SARS-CoV-2 infection is essential for elucidating the pathophysiology and virulence of COVID-19. Methods: This study included 40 hospitalized COVID-19 patients and 40 healthy controls. Serum metabolic profiles were analyzed using ultra-high-pressure liquid chromatography-mass spectrometry (UHPLC-MS), and cytokine levels were measured using ELISA. Results: Our study defined three clear metabolic phenotypes among survivors and non-survivors of COVID-19 compared with healthy controls, which might be related to mortality, severity, and disease burden. A strong relationship was observed between certain inflammatory markers, including IL-1β, IL-2, IFN-β, IFN-γ, IL-17, and GM-CSF, as well as several metabolites, particularly in COVID-19 non-survivors, such as LysoPCs, 3-hydroxykynurenine, and serotonin. Different metabolite-cytokine correlation patterns were observed according to patient outcomes, indicating unique correlations between metabolic and immune responses in survivors and non-survivors. Metabolic phenotypes were associated with clinical outcomes, comorbidities, and sex-related differences. Kynurenine and related metabolites of tryptophan metabolism were closely correlated with COVID-19 severity, age, and mortality. Compared with survivors and healthy controls, non-survivors displayed higher IL-6, together with distinct metabolic changes. These included increased kynurenine through the IDO1 pathway, elevated glucose and lactate reflecting hyperglycolysis and energy stress, and higher xanthosine from purine turnover. Stronger cytokine–metabolite correlations in this group point to tightly linked immunometabolic activation. Conclusions: Metabolomic profiling revealed distinct metabolic phenotypes that could be associated with the severity and inflammation levels of COVID-19. Correlation analysis between metabolites and cytokines demonstrated strong intercorrelations between specific metabolites and cytokines, indicating a strong interrelationship between inflammatory markers and metabolic alterations. Specific metabolic pathways associated with cytokines and their clinical relevance may serve as potential therapeutic targets.
Full article
(This article belongs to the Special Issue Mass Spectrometry-Based Metabolomics in Health and Disease: Targeted Analysis and Its Trends)
►▼
Show Figures

Figure 1
Open AccessReview
NMR-Based Metabolomic Profiling for Brain Cancer Diagnosis and Treatment Guidance
by
Julia R. Zickus, José S. Enriquez, Paytience Smith, Bill T. Sun, Muxin Wang, Aldo Morales, Pratip K. Bhattacharya and Shivanand Pudakalakatti
Metabolites 2025, 15(9), 607; https://doi.org/10.3390/metabo15090607 - 11 Sep 2025
Abstract
Nuclear magnetic resonance (NMR) spectroscopy is a routinely used analytical tool for studying chemical entities of varying molecular sizes, ranging from approximately 20 Da to ~45 kDa, and in some cases even larger. Over the past two decades, the use of NMR spectroscopy
[...] Read more.
Nuclear magnetic resonance (NMR) spectroscopy is a routinely used analytical tool for studying chemical entities of varying molecular sizes, ranging from approximately 20 Da to ~45 kDa, and in some cases even larger. Over the past two decades, the use of NMR spectroscopy has significantly expanded to the study of metabolomics. In this medium-sized review, the application of NMR-based metabolomics in the diagnosis, therapeutic intervention, and guidance of therapy for various types of brain cancer is discussed.
Full article
(This article belongs to the Special Issue Harnessing the Power of NMR Metabolomics in Unraveling Metabolic Diseases)
►▼
Show Figures

Graphical abstract
Open AccessArticle
The Metabolic Vulnerability Index (MVX) in Subclinical Thyroid Disorders and Euthyroidism: A Cross-Sectional Exploratory Analysis from the ELSA-Brasil Study
by
Carolina Castro Porto Silva Janovsky, Vandrize Meneghini, William Tebar, Joao Roberto Maciel Martins, José Augusto Sgarbi, Patrícia de Fatima dos Santos Teixeira, Itamar de Souza Santos, Steven R. Jones, Michael J. Blaha, Peter P. Toth, Marcio S. Bittencourt, Raul D. Santos, Paulo A. Lotufo, Layal Chaker and Isabela M. Bensenor
Metabolites 2025, 15(9), 606; https://doi.org/10.3390/metabo15090606 - 11 Sep 2025
Abstract
Background: Recently, a new biomarker index that reflects inflammation and protein energy malnutrition has emerged as a predictor of mortality in cardiovascular diseases. The metabolic vulnerability index (MVX) derives from blood-based inflammation (IVX) and malnutrition (MMX) markers measured by nuclear magnetic resonance (NMR)
[...] Read more.
Background: Recently, a new biomarker index that reflects inflammation and protein energy malnutrition has emerged as a predictor of mortality in cardiovascular diseases. The metabolic vulnerability index (MVX) derives from blood-based inflammation (IVX) and malnutrition (MMX) markers measured by nuclear magnetic resonance (NMR) spectroscopy. We aimed to explore the association of subclinical hypothyroidism and thyroid-related parameters with IVX, MMX, and MVX scores. Methods: This cross-sectional study used the baseline data from the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). Individuals with normal thyroid function and subclinical hypothyroidism were included. Thyroid-related parameters—thyroid-stimulating hormone (TSH), free thyroxine (FT4), free triiodothyronine (FT3), the FT3–FT4 ratio, and antithyroperoxidase antibodies (TPOAb)—were the explanatory variables. The primary outcomes, MVX, MMX, and IVX scores, were analyzed as continuous variables. Linear regression analyses were performed for both univariate and multivariable models, with sensitivity and subgroup analyses applied to assess robustness. Findings: There were 3979 participants (51.4% female) with a mean age of 51.26 (SD: 9.02) years. After full adjustment for potential confounder variables, FT3 levels [B: −1.37 (−2.43;−0.31) p = 0.011] and the FT3–FT4 ratio [B: −0.90 (−1.79;−0.01) p = 0.047] were inversely associated with MVX scores. FT3 levels were also inversely associated with IVX [B: −1.32 (−2.39;−0.24) p = 0.017]. These results were consistent in euthyroid individuals and those with cardiometabolic diseases. In the sex-stratified analysis, FT3 levels were inversely associated with MVX, MMX, and IVX scores for men. Conclusion: Lower FT3 levels and the FT3–FT4 ratio were associated with a higher metabolic vulnerability in our cohort. Our study sheds light on the importance of metabolic surveillance in these patients, especially for men with cardiometabolic diseases.
Full article
(This article belongs to the Section Endocrinology and Clinical Metabolic Research)
►▼
Show Figures

Figure 1
Open AccessArticle
Enzymatic Evolution and Longitudinal Recovery in Biotinidase Deficiency: Genotypic and Clinical Insights from the Follow-Up of a Newborn-Screened Cohort in Emilia-Romagna, Italy
by
Rita Ortolano, Soara Menabò, Egidio Candela, Giacomo Biasucci, Elisa Bortolamedi, Giulia Montanari, Alessandro Zuccotti, Umberto Cattini, Marcello Lanari and Federico Baronio
Metabolites 2025, 15(9), 605; https://doi.org/10.3390/metabo15090605 - 10 Sep 2025
Abstract
Background/Objectives: Biotinidase deficiency (BD) is a treatable autosomal recessive disorder included in many newborn screening (NBS) programs. The importance of early diagnosis and treatment is now well established. However, recent studies are emerging on the possibility of increased enzyme activity with age, an
[...] Read more.
Background/Objectives: Biotinidase deficiency (BD) is a treatable autosomal recessive disorder included in many newborn screening (NBS) programs. The importance of early diagnosis and treatment is now well established. However, recent studies are emerging on the possibility of increased enzyme activity with age, an observation that raises questions about the long-term validity of the initial classification of these patients. This study aimed to assess the incidence, genetic and clinical features, and, notably, the longitudinal enzymatic trajectory of BD in a cohort identified by NBS in Emilia-Romagna, Italy, with implications for diagnostic re-evaluation and therapeutic decisions. Methods: A retrospective and prospective analysis was conducted on 64 infants recalled after NBS for suspected BD between 2016 and 2020. Biochemical, molecular, and clinical data were collected, and biotinidase (BTD) activity was monitored longitudinally. Affected individuals were supplemented with biotin and followed clinically for at least 5 years. Results: Thirty-one patients were diagnosed with BD (30 partial, 1 profound; incidence 1:5448). A significant and sustained increase in BTD activity was observed from diagnosis through early childhood (p < 0.001 up to 60 months), particularly among patients carrying the p.Asp444His variant. This enzymatic trend suggests a potential remodulation of biochemical classification over time. Genotype–phenotype concordance was high (92%), and clinical outcomes were favorable across the cohort. Conclusions: This study provides new evidence that BTD activity in patients with BD increases progressively, supporting the concept of age-dependent enzyme recovery. Our results support the need for systematic re-evaluation of diagnosis and treatment, especially at 12 months of age, and particularly in patients with evidence of partial activity deficiency and the p.Asp444His mutation.
Full article
(This article belongs to the Special Issue Research of Inborn Errors of Metabolism)
►▼
Show Figures

Figure 1
Open AccessArticle
Organ-Specific Metabolome Reveals Potential Nutritional and Health Benefits of Ampelopsis grossedentata
by
Yanna Li, Ran Ye, Ju Yang, Siting Deng, Dongqing Rong, Yinling Luo and Hui Huang
Metabolites 2025, 15(9), 604; https://doi.org/10.3390/metabo15090604 - 10 Sep 2025
Abstract
Background/Objectives: Ampelopsis grossedentata, a novel food resource (vine tea), is a therapeutically valuable species wherein all parts exhibit bioactive potential. The therapeutic value and health benefits of A. grossedentata are rooted in its metabolomic profile, yet the metabolites in its various parts
[...] Read more.
Background/Objectives: Ampelopsis grossedentata, a novel food resource (vine tea), is a therapeutically valuable species wherein all parts exhibit bioactive potential. The therapeutic value and health benefits of A. grossedentata are rooted in its metabolomic profile, yet the metabolites in its various parts remain incompletely characterized. In this study, the tissue-specific biochemical properties and metabolic profiles of A. grossedentata were systematically characterized to identify the optimal tissue type for harvesting, with the goal of maximizing the production of bioactive compounds. Methods: The biochemical properties of various A. grossedentata tissues were assessed using a spectrophotometer, and their metabolic profiles were characterized through LC-MS/MS-based untargeted metabolomics. Results: The results demonstrate that, compared with the stems and roots, the tender leaves and floral tissues contained a higher TFC and TPC, correlating with superior antioxidant activity (DPPH, ABTS, and FRAP). A metabolic analysis revealed that the tender leaves accumulated multiple bioactive flavonoids beyond dihydromyricetin, including naringenin 7-O-beta-D-glucoside, (-)-epigallocatechin, tricetin, and cyanidin 3-O-sophoroside. The floral tissues displayed a comparable antioxidant capacity and dihydromyricetin level to the leaves, as well as unique compounds, such as leucodelphinidin, naringenin, epicatechin, dihydroquercetin, astilbin, and myricitrin. A metabolomic analysis further demonstrated a high accumulation of L-glutamine and L-glutamic acid in the floral tissues, potentially contributing to the characteristic umami flavor profile of vine tea made from A. grossedentata flowers. Conclusions:A. grossedentata flowers could be considered a promising raw material for developing novel functional foods and premium herbal tea products, as they possess superior antioxidant activity and abundant flavonoids and amino acids.
Full article
(This article belongs to the Special Issue Advances in Food Metabolomics for Functional Food Development and Analysis)
►▼
Show Figures

Graphical abstract
Open AccessArticle
Seed Metabolomic Landscape Reflecting Key Differential Metabolic Profiles Among Different Wheat Cultivars
by
Kgalaletso Othibeng, Lerato Nephali and Fidele Tugizimana
Metabolites 2025, 15(9), 603; https://doi.org/10.3390/metabo15090603 - 10 Sep 2025
Abstract
Background: Adverse environmental conditions and an ever-increasing world population require devising and designing a roadmap for the next generation of wheat crops for high productivity and resilience to climate change. As such, a fundamental understanding of wheat metabolism and molecular descriptors of
[...] Read more.
Background: Adverse environmental conditions and an ever-increasing world population require devising and designing a roadmap for the next generation of wheat crops for high productivity and resilience to climate change. As such, a fundamental understanding of wheat metabolism and molecular descriptors of wheat seed potentials and quality is a sine qua non step. Objectives: In this study we investigated the seed metabolomes of five wheat cultivars to identify differential metabolic profiles and cultivar-related metabolic markers. Methods: Liquid chromatography-mass spectrometry (LC-MS) combined with computational strategies and functional analyses was applied. Metabolites were extracted using methanol, and samples were analysed on an LC-MS/MS system. Results: The results revealed that the extracted wheat cultivar seed metabolomes spanned a broad range of metabolite classes, including alkaloids, sugars, phenolics, amino acids, hormones, TCA compounds and lipids. Furthermore, the results also revealed key metabolic markers differentiating the wheat cultivars from one another, such as lipids (i.e., MGMG and 13-HODE) and flavonoids (i.e., rutin, tricin and vitexin), amongst many others. Conclusions: Such insights are important in assessing seed quality as well as in the selection of markers for seed nutrient and quality trait improvement in wheat breeding programmes. As such, this work generates novel actionable knowledge, a comprehensive metabolomic landscape of wheat seeds and potential markers for cultivar differentiation and quality assessment, which is essential for sustainable and improved wheat production. Thus, the study contributes towards the realisation of sustainable food security, an urgent call for action in a global partnership, as articulated in the United Nations Sustainable Development Goals, particularly zero hunger.
Full article
(This article belongs to the Section Plant Metabolism)
►▼
Show Figures

Figure 1
Open AccessReview
Impact of Dietary Interventions on the Human Plasma and Lipoprotein Lipidome
by
Rosa Casas, Nancy D. Sánchez-García, Ramon Estruch and Anallely López-Yerena
Metabolites 2025, 15(9), 602; https://doi.org/10.3390/metabo15090602 - 9 Sep 2025
Abstract
Lipids are structurally diverse biomolecules that play essential roles in cellular function, energy storage, and signaling. The human lipidome, a dynamic and complex subset of the metabolome, is shaped by both endogenous factors, such as genetics, sex, age, and metabolic health, and exogenous
[...] Read more.
Lipids are structurally diverse biomolecules that play essential roles in cellular function, energy storage, and signaling. The human lipidome, a dynamic and complex subset of the metabolome, is shaped by both endogenous factors, such as genetics, sex, age, and metabolic health, and exogenous influences like lifestyle, diet, and microbiota. Among these, diet stands out as one of the most modifiable and impactful determinants, influencing lipid composition across plasma, serum, and lipoprotein fractions. While traditional lipid profiling provides limited insight, lipidomics enables comprehensive characterization of lipid species, revealing mechanistic links between lipid metabolism and diseases such as cardiovascular disease (CVD), metabolic syndrome (MetS), and inflammatory disorders. This review explores: (1) the relationship between lipid profiles and CVD risk, (2) the internal and external modulators of the lipidome, and (3) current evidence on how specific dietary patterns, including Mediterranean, Nordic, low glycemic, and vegetarian diets, and individual nutrients such as omega-3 fatty acids (FAs), plant sterols, and mycoprotein, influence lipidomic profiles. Advances in lipidomics highlight that dietary fat quality, food matrix, and eating patterns can significantly modulate lipid species such as triacylglycerols (TAGs), ceramides (Cers), and phospholipids, with implications for cardiometabolic health. Notably, distinct responses are observed across plasma High-Density Lipoprotein (HDL) and Low-Density Lipoprotein (LDL) lipidomes, emphasizing the need for compartment-specific analyses. Understanding these diet-lipidome interactions offers promising avenues for precision nutrition and the development of lipid-based biomarkers for disease prevention and management.
Full article
(This article belongs to the Special Issue Food Intake and Bioactive Metabolism in Humans)
►▼
Show Figures

Figure 1
Open AccessReview
Amino Acid Metabolism of the Skin: Control by Specific Enzymes and Contribution to Protective Functions
by
Corina Dörner, Julia Steinbinder, Attila Placido Sachslehner, Supawadee Sukseree and Leopold Eckhart
Metabolites 2025, 15(9), 601; https://doi.org/10.3390/metabo15090601 - 9 Sep 2025
Abstract
The skin protects the body from damaging external stressors. The function of its outermost compartment, the epidermis, depends on high rates of protein synthesis and the production of protective molecules, both requiring amino acids as precursors. Conversely, the degradation of the epidermal barrier
[...] Read more.
The skin protects the body from damaging external stressors. The function of its outermost compartment, the epidermis, depends on high rates of protein synthesis and the production of protective molecules, both requiring amino acids as precursors. Conversely, the degradation of the epidermal barrier protein filaggrin releases free amino acids. Here, we review the epidermal amino acid metabolism, focusing on the metabolism of histidine, arginine and tyrosine, which are subjected to epidermal cell-specific control mechanisms. Histidine and arginine are metabolized by enzymes that are transcriptionally upregulated during terminal differentiation of keratinocytes, while tyrosine is specifically metabolized in melanocytes. Arginase converts arginine into ornithine and urea. While ornithine is decarboxylated to putrescine, a regulator of cellular proliferation, urea contributes to the moisturization of the skin surface. Histidase, also known as histidine ammonia lyase, converts histidine into urocanic acid (UCA) and ammonia. UCA is the main ultraviolet-absorbing molecule of the cornified layer of the epidermis, serving as a natural sunscreen of human skin. In melanocytes, tyrosinase initiates the polymerization of tyrosine to melanin, the main skin pigment that absorbs both visible light and ultraviolet radiation. The current evidence indicates that the metabolism of histidine, arginine, tyrosine and other amino acids critically influences normal and diseased skin.
Full article
(This article belongs to the Section Cell Metabolism)
►▼
Show Figures

Figure 1
Open AccessArticle
Time-Resolved Metabolomics Reveals Mitochondrial Protection in Septic Liver Injury
by
Naoki Suzuki, Shoichiro Shibata, Masahiro Sugimoto, Eskil Elmer and Hiroyuki Uchino
Metabolites 2025, 15(9), 600; https://doi.org/10.3390/metabo15090600 - 9 Sep 2025
Abstract
Background/Objectives: Sepsis is a life-threatening condition characterized by organ dysfunction due to a dysregulated host response to infection. Mitochondrial dysfunction is considered a key contributor to the pathogenesis of sepsis, but its molecular mechanisms remain unclear. Methods: In this study, we
[...] Read more.
Background/Objectives: Sepsis is a life-threatening condition characterized by organ dysfunction due to a dysregulated host response to infection. Mitochondrial dysfunction is considered a key contributor to the pathogenesis of sepsis, but its molecular mechanisms remain unclear. Methods: In this study, we used a cecal ligation and puncture (CLP) model to induce sepsis in wild-type (WT) and cyclophilin D knockout (CypD KO) mice. Liver tissues were collected at 0, 6, and 18 h post-CLP and analyzed using liquid chromatography–tandem mass spectrometry (LC-MS/MS). Results: Metabolomic profiling revealed that lactate levels significantly increased in the WT mice but remained stable in the KO mice. While AMP levels were preserved in the KO mice, these mice had significantly higher glutathione disulfide (GSSG) and spermidine concentrations than the WT mice at 18 h (p < 0.05). The levels of malondialdehyde (MDA), a marker of oxidative stress, were also significantly lower in the KO mice at 18 h (p < 0.05). These findings suggest that CypD deficiency preserves mitochondrial function, enhances resistance to oxidative stress, and mitigates septic liver injury. Conclusions: Our results highlight the potential of targeting mitochondrial permeability transition as a therapeutic strategy for sepsis.
Full article
(This article belongs to the Section Endocrinology and Clinical Metabolic Research)
►▼
Show Figures

Graphical abstract
Open AccessArticle
Dietary Intervention with Cottonseed and Olive Oil Differentially Affect the Circulating Lipidome and Immunoregulatory Compounds—A Randomized Clinical Trial
by
Gwendolyn Cooper, Prabina Bhattarai, Brett Sather, Marguerite L. Bailey, Morgan Chamberlin, Mary Miles and Brian Bothner
Metabolites 2025, 15(9), 599; https://doi.org/10.3390/metabo15090599 - 8 Sep 2025
Abstract
Background/Objectives: Cottonseed oil (CSO) is a dietary oil especially high in the n-6 polyunsaturated fatty acid (PUFA), linoleic acid (FA 18:2), which is a precursor for many pro-inflammatory eicosanoids. Curiously, diets rich in CSO have not been shown to cause increases in
[...] Read more.
Background/Objectives: Cottonseed oil (CSO) is a dietary oil especially high in the n-6 polyunsaturated fatty acid (PUFA), linoleic acid (FA 18:2), which is a precursor for many pro-inflammatory eicosanoids. Curiously, diets rich in CSO have not been shown to cause increases in inflammatory markers or other negative health outcomes in humans. To rigorously test this, we have compared the health impact of a diet rich in CSO to olive oil (OO), which is generally considered to be a healthy oil. Methods: Specifically, this study examines circulating metabolite and lipid profiles during a 4-week dietary intervention with CSO or OO on 47 healthy adults. Untargeted metabolomics, targeted bulk lipidomics, and targeted lipid mediator analyses were conducted on fasting plasma samples taken pre- and post-dietary intervention. Results: A high degree of similarity was observed in the global metabolomic profiles of CSO and OO participants, indicating that CSO may elicit metabolic responses comparable to those of OO, potentially supporting similar effects on metabolic health markers. Targeted bulk lipidomics revealed changes in acyl chain composition reflective of the dominant fatty acid consumed—either 18:2 in CSO or 18:1 in OO. Immunoregulatory lipids 15-deoxy-PGJ2 and prostaglandin F2 alpha (PGF2a) were both higher in abundance in high-CSO diets, demonstrating differential effects of CSO and OO on immunoregulatory compounds. A correlative network analysis revealed two clusters arising from the dietary intervention as drivers of the dietary and immune responses. Conclusions: This study shows that CSO and OO differentially impact the circulating lipidome and immunoregulatory compounds in healthy adults.
Full article
(This article belongs to the Special Issue Advances in Food Metabolomics for Functional Food Development and Analysis)
►▼
Show Figures

Figure 1
Open AccessArticle
Glutamine and Albumin Levels in Cerebrospinal Fluid Are Correlated with Neurological Severity in an Experimental Model of Acute Hepatic Encephalopathy
by
Pedro Arend Guazzelli, Felipe dos Santos Fachim, Anderson Santos Travassos, Caroline Casagrande Schaukoski, Pâmela Cristina Lukasewicz Ferreira, Fernanda Uruth Fontella, Marco Antônio de Bastiani, Adriano Martimbianco de Assis and Diogo Onofre Souza
Metabolites 2025, 15(9), 598; https://doi.org/10.3390/metabo15090598 - 8 Sep 2025
Abstract
Background/Objectives: Hepatic encephalopathy (HE) is a severe neurological complication of acute liver failure (ALF) characterized by the accumulation of neurotoxic metabolites and impaired cerebral function. We aimed to examine the correlation between HE severity and cerebrospinal fluid (CSF) biomarker levels in a rat
[...] Read more.
Background/Objectives: Hepatic encephalopathy (HE) is a severe neurological complication of acute liver failure (ALF) characterized by the accumulation of neurotoxic metabolites and impaired cerebral function. We aimed to examine the correlation between HE severity and cerebrospinal fluid (CSF) biomarker levels in a rat model of ALF induced by subtotal hepatectomy. Methods: Male Wistar rats underwent 92% hepatectomy and were monitored for neurological impairment via a standardized HE score. At twenty-four hours post surgery, CSF and blood were collected for biochemical analysis. Results: We found a significant positive correlation between neurological severity and CSF levels of glutamine (r = 0.929, p < 0.001) and albumin (r = 0.869, p < 0.001), both with HE grade I scores, highlighting their prominent role as HE biomarkers. Other amino acids, including aspartate (r = 0.790, p < 0.001), glutamate (r = 0.853, p < 0.001), isoleucine (r = 0.834, p < 0.001), leucine (r = 0.813, p < 0.001), lysine (r = 0.861, p < 0.001), methionine (r = 0.889, p < 0.001), phenylalanine (r = 0.916, p < 0.001), ornithine (r = 0.775, p < 0.001), tryptophan (r = 0.814, p < 0.001), and valine (r = 0.721, p < 0.001), also showed significant correlations with HE severity but not with HE grade I scores. Conclusions: These findings underscore the potential of glutamine and albumin in CSF as key biomarkers for assessing neurological severity in ALF patients.
Full article
(This article belongs to the Special Issue Metabolic Profiling in Neurometabolisms)
►▼
Show Figures

Figure 1
Open AccessArticle
Methods for Untargeted Analysis of Milk Metabolites: Influence of Extraction Method and Optimization of Separation
by
Daisy Wilkie, Brad White, Golnaz Heidari, Rafea Naffa, Gaile Peddie, Gareth J. Rowlands and Paul G. Plieger
Metabolites 2025, 15(9), 597; https://doi.org/10.3390/metabo15090597 - 8 Sep 2025
Abstract
Background/Objectives: Cow’s milk is a complex food, and research into its metabolome can provide information useful in the study of animal health, farming practices, food safety and the adulteration of milk. Comparative interlaboratory metabolic analysis is hampered by the lack of standardized methods—a
[...] Read more.
Background/Objectives: Cow’s milk is a complex food, and research into its metabolome can provide information useful in the study of animal health, farming practices, food safety and the adulteration of milk. Comparative interlaboratory metabolic analysis is hampered by the lack of standardized methods—a requirement addressed in this study. Methods: We studied the influence of the chromatography column and extraction solvent on the metabolites isolated during untargeted metabolomics. Results: After studying fifteen columns and four extraction solvents, it was determined that an HILIC column offered the best compromise between retention time and separation of metabolites. Each extraction solvent covered a different area of the metabolome, only overlapping with previously annotated compounds. Extraction mixtures containing methanol tend to give better recovery. Conclusions: The choice of extraction solvent was crucial when looking at the difference between samples, but if interest lies only in previously annotated compounds, then there is little difference between the solvents.
Full article
(This article belongs to the Section Food Metabolomics)
►▼
Show Figures

Graphical abstract
Open AccessArticle
Effects of 12 Weeks of Calanus Oil Supplementation on Cardiac Diastolic Function in Obese and Prediabetic Women—A Pilot Study
by
Felix Kerlikowsky, Fabian Spahiu, Eric J. Stöhr, Sina Junge, Wiebke Jonas, Edda van de Flierdt, Jan Philipp Schuchardt and Andreas Hahn
Metabolites 2025, 15(9), 596; https://doi.org/10.3390/metabo15090596 - 8 Sep 2025
Abstract
Background/Objectives: In early-stage diabetes, diastolic dysfunction is an initial indicator of heart failure and is linked to altered glucose metabolism, including in prediabetes. Based on initial evidence that Calanus oil, derived from Calanus finmarchicus, which is rich in omega-3 polyunsaturated fatty acids
[...] Read more.
Background/Objectives: In early-stage diabetes, diastolic dysfunction is an initial indicator of heart failure and is linked to altered glucose metabolism, including in prediabetes. Based on initial evidence that Calanus oil, derived from Calanus finmarchicus, which is rich in omega-3 polyunsaturated fatty acids and other bioactive compounds, benefits metabolic and cardiorespiratory health, this proof-of-principle study aimed to assess whether Calanus oil improves diastolic function in prediabetic women. Methods: Twenty middle-aged, obese women with prediabetes and no history of cardiac complications were enrolled and received 4 g/day of Calanus oil, providing 276 mg EPA + 256 mg DHA, for 12 weeks. Systolic and diastolic cardiac function, including the E/A ratio (E/A), was assessed by echocardiography. In addition, central blood pressure (BP) and pulse wave velocity (PWV) were analyzed by oscillometry. Metabolic health was evaluated using composite markers, including the metabolic syndrome severity score (Met-S score) and the triacylglycerol glucose–waist-to-height ratio (TyG-WHtR). Results: E/A was significantly improved (p = 0.023) following 12 weeks of Calanus oil supplementation. Furthermore, a significant improvement in metabolic health, indicated by a reduced Met-S score and a lower TyG-WHtR, was noticed (p < 0.001, respectively), reflecting decreased metabolic syndrome severity and enhanced insulin sensitivity. In addition, a significant reduction in diastolic BP, resting heart rate (p = 0.047), but not PWV or systolic BP (all p > 0.05) was observed. The improvement in E/A was associated with improved insulin sensitivity, as reflected by a decrease in the TyG-WHtR (p = 0.014). Conclusions: These exploratory findings suggest that Calanus oil supplementation in pre-diabetic women might improve central diastolic haemodynamics, accompanied by an overall improvement in metabolic health. However, the absence of a placebo control group limits definitive conclusions.
Full article
(This article belongs to the Section Endocrinology and Clinical Metabolic Research)
►▼
Show Figures

Figure 1
Open AccessReview
Fatty Acid Profile and Desaturase Activity in Obesity: Roles, Mechanisms, and Clinical Relevance
by
Michalina Banaszak, Ilona Górna and Sławomira Drzymała-Czyż
Metabolites 2025, 15(9), 595; https://doi.org/10.3390/metabo15090595 - 8 Sep 2025
Abstract
Background: Obesity is a complex metabolic disease associated with several health complications, including insulin resistance, hypertension, and type 2 diabetes mellitus. Growing evidence indicates that fatty acid profiles and the activity of desaturating enzymes—stearoyl-CoA desaturase-1 (SCD1), delta-5 desaturase (D5D), and delta-6 desaturase (D6D)—are
[...] Read more.
Background: Obesity is a complex metabolic disease associated with several health complications, including insulin resistance, hypertension, and type 2 diabetes mellitus. Growing evidence indicates that fatty acid profiles and the activity of desaturating enzymes—stearoyl-CoA desaturase-1 (SCD1), delta-5 desaturase (D5D), and delta-6 desaturase (D6D)—are important factors in the pathophysiology of obesity. This review aims to summarise the current understanding of the alterations in lipid metabolism and desaturase activity in obesity, its complications, and potential therapeutic interventions. Methods: A literature review was performed using the PubMed, Scopus, and Web of Science databases. Systematic reviews, meta-analyses, clinical studies, cross-sectional studies, and animal studies that assessed fatty acid profiles and desaturase activity in the context of obesity were included. Results: Obesity is associated with significant changes in the profiles of saturated fatty acids (SFAs), monounsaturated fatty acids (MUFAs), and polyunsaturated fatty acids (PUFAs), as well as altered desaturase activity. Increased activity of SCD1 and D6D and decreased activity of D5D are observed even in childhood and correlate with metabolic risk markers. Genetic variation in genes encoding fatty acid desaturases, such as fatty acid desaturase 1 (FADS1), fatty acid desaturase 2 (FADS2), and SCD1, influences lipid metabolism and susceptibility to metabolic disorders. Nutritional interventions, supplementation (e.g., omega-3 fatty acids, L-carnitine, and crocin), physical activity, and bariatric surgery positively influence the fatty acid profile and enzymatic activity, modifying the risk of obesity-related diseases. Conclusions: Fatty acid profile and desaturase activity are significantly altered in obesity and represent potential biomarkers and therapeutic targets for its treatment and the prevention of related complications. Their assessment may contribute to a more personalised approach to treating obesity and associated metabolic diseases.
Full article
(This article belongs to the Special Issue Lipid Metabolism Disorders in Obesity)
►▼
Show Figures

Figure 1
Open AccessArticle
Phenolic-Rich Indian Almond (Terminalia catappa Linn) Leaf Extract Ameliorates Lipid Metabolism and Inflammation in High-Fat Diet (HFD)-Induced Obese Mice
by
Opeyemi O. Deji-Oloruntoba, Ji Eun Kim, Hee Jin Song, Ayun Seol, Dae Youn Hwang and Miran Jang
Metabolites 2025, 15(9), 594; https://doi.org/10.3390/metabo15090594 - 8 Sep 2025
Abstract
Background: Obesity is a global health issue closely associated with dysregulated lipid metabolism and chronic inflammation. Effective strategies targeting both lipogenesis and inflammation are essential for managing obesity and its related metabolic disorders. Methods: This study evaluated the effects of Terminalia catappa Linn.
[...] Read more.
Background: Obesity is a global health issue closely associated with dysregulated lipid metabolism and chronic inflammation. Effective strategies targeting both lipogenesis and inflammation are essential for managing obesity and its related metabolic disorders. Methods: This study evaluated the effects of Terminalia catappa Linn. leaf extract (TCE) on lipogenic and lipolytic pathways in high-fat diet (HFD)-induced obese mice. UPLC-QTOF-MS analysis was conducted to identify and quantify the major phenolic compounds in TCE. Mice were administered low and high doses of TCE, and various metabolic parameters, including lipid profiles, liver function markers, adipokine levels, and gene/protein expressions related to lipid metabolism and inflammation, were assessed. Results: UPLC-QTOF-MS analysis identified four major phenolic compounds in TCE—gallic acid, orientin, vitexin, and ellagic acid—with respective contents of 112.5, 163.3, 184.7, and 295.7 mg/g extract. TCE administration significantly reduced liver and adipose tissue weights, along with hepatic and adipose lipid accumulation. Both low and high doses of TCE markedly lowered serum lipid levels. Liver function was improved, as indicated by reduced levels of AST, ALT, and ALP, while BUN levels remained unchanged. On the molecular level, TCE downregulated adipogenic and lipogenic genes (PPARγ, PPARα, C/EBPα, aP2) and upregulated metabolic regulators, including leptin, adiponectin, p-HSL/HSL, and p-perilipin/perilipin, without affecting ATGL expression. TCE also suppressed pro-inflammatory cytokines such as IL-6, IL-1β, TNF-α, and TGFβ-1. Conclusions: These findings highlight the therapeutic potential of TCE in managing obesity by inhibiting lipogenesis, enhancing lipolysis, and reducing inflammation.
Full article
(This article belongs to the Section Pharmacology and Drug Metabolism)
►▼
Show Figures

Graphical abstract
Open AccessArticle
Multiparametric Evaluation of Drug-Induced Acute Kidney Injury Using Preclinical 7T Magnetic Resonance Imaging in Rat Models
by
Tomohiro Natsuyama, Junpei Ueda, Isamu Yabata, Reika Sawaya, Koji Itagaki and Shigeyoshi Saito
Metabolites 2025, 15(9), 593; https://doi.org/10.3390/metabo15090593 - 7 Sep 2025
Abstract
Objectives: Acute kidney injury (AKI), characterized by a rapid decline in renal function, affects approximately 13 million new patients annually. Adverse drug reactions have increasingly contributed to renal injury, underscoring the need for methods to directly and quantitatively evaluate renal injury. Methods
[...] Read more.
Objectives: Acute kidney injury (AKI), characterized by a rapid decline in renal function, affects approximately 13 million new patients annually. Adverse drug reactions have increasingly contributed to renal injury, underscoring the need for methods to directly and quantitatively evaluate renal injury. Methods: We utilized a drug-induced AKI model using gentamicin overdose, combining 7T magnetic resonance imaging (MRI) relaxation time measurements and blood tests to evaluate pathophysiological changes from multiple perspectives. Ten-week-old Wistar rats received intraperitoneal administration of gentamicin (80 mg/kg) for 7 days. Under respiratory synchronization, T1, T1rho, T2, and T2* maps were obtained in six control and five disease model rats. Relaxation times in the cortex and medulla were measured separately and compared between groups. Results: Blood tests evaluated Na, K, Cl, blood urea nitrogen, creatinine, and hematocrit levels. Renal tissue damage was evaluated via hematoxylin and eosin (HE) staining. Relaxation time showed significant changes in the cortex, especially in the T1 (control: 1156.7 ± 140.0, gentamicin: 1550.4 ± 162.1, p < 0.05) and T2 (control: 42.9 ± 3.4, gentamicin: 53.4 ± 4.8, p < 0.05) maps. Blood tests revealed significant increases in Na, blood urea nitrogen, creatinine, and hematocrit levels in the disease model. A correlation was observed between the T1 map of the renal cortex and each substance. HE staining revealed tissue damage due to renal injury. Conclusions: Multiparametric MRI facilitates quantitative and multidimensional evaluation of renal pathological changes caused by drug-induced AKI.
Full article
(This article belongs to the Special Issue Integration of Emerging Technologies in Metabolite Analysis)
►▼
Show Figures

Figure 1
Open AccessArticle
Plasma Lipidomic Alterations in Fontan Circulation Reflect Cardiovascular Functional Reserve
by
Arun Surendran, Amir Ravandi and Ashish H. Shah
Metabolites 2025, 15(9), 592; https://doi.org/10.3390/metabo15090592 - 7 Sep 2025
Abstract
Background: Fontan circulation is associated with impaired cardiac output, reduced exercise capacity, and systemic metabolic stress. However, the underlying lipidomic alterations remain poorly defined. Methods: Using targeted mass spectrometry, we analyzed 291 lipid species in fasting plasma samples from 20 adults with Fontan
[...] Read more.
Background: Fontan circulation is associated with impaired cardiac output, reduced exercise capacity, and systemic metabolic stress. However, the underlying lipidomic alterations remain poorly defined. Methods: Using targeted mass spectrometry, we analyzed 291 lipid species in fasting plasma samples from 20 adults with Fontan circulation and 20 age- and sex-matched healthy controls. Results: Forty-eight lipids were significantly altered between groups (p < 0.05), including reductions in total lysophosphatidylcholines (LPC) and total ether-linked LPC [LPC(O)] and elevations in total phosphatidylserines (PS). Notably, LPC(O-22:1) and LPC(O-20:0) were decreased, while PS 40:5 was elevated, with several of these species demonstrating strong correlations (|r| > 0.5, p < 0.001) with the stroke index, cardiac index, and VO2max. These three lipid species also showed excellent capability in discriminating Fontan patients from healthy controls (AUC > 0.78). Correlation network and pathway enrichment analyses revealed tightly coordinated lipid clusters containing LPC/LPC(O), PE, and PS species as central features of dysregulated Fontan metabolism. Conclusions: These exploratory findings highlight coordinated lipid alterations associated with impaired cardiovascular reserve in Fontan patients. While based on unadjusted p-values and therefore being hypothesis-generating, they provide novel insight into the metabolic landscape of Fontan physiology and warrant validation in larger, independent cohorts.
Full article
(This article belongs to the Special Issue Lipid Metabolism Dysregulation in Metabolic Disorders: Unraveling the Molecular Complexity)
►▼
Show Figures

Figure 1

Journal Menu
► ▼ Journal Menu-
- Metabolites Home
- Aims & Scope
- Editorial Board
- Reviewer Board
- Topical Advisory Panel
- Instructions for Authors
- Special Issues
- Topics
- Sections & Collections
- Article Processing Charge
- Indexing & Archiving
- Editor’s Choice Articles
- Most Cited & Viewed
- Journal Statistics
- Journal History
- Journal Awards
- Conferences
- Editorial Office
Journal Browser
► ▼ Journal BrowserHighly Accessed Articles
Latest Books
E-Mail Alert
News
3 September 2025
Join Us at the MDPI at the University of Toronto Career Fair, 23 September 2025, Toronto, ON, Canada
Join Us at the MDPI at the University of Toronto Career Fair, 23 September 2025, Toronto, ON, Canada

1 September 2025
MDPI INSIGHTS: The CEO’s Letter #26 – CUJS, Head of Ethics, Open Peer Review, AIS 2025, Reviewer Recognition
MDPI INSIGHTS: The CEO’s Letter #26 – CUJS, Head of Ethics, Open Peer Review, AIS 2025, Reviewer Recognition
Topics
Topic in
Agronomy, Metabolites, Microorganisms, Plants, Soil Systems
Interactions between Plants and Soil Microbes in Natural Ecosystem
Topic Editors: Chao Zhang, Jie WangDeadline: 31 October 2025
Topic in
Cells, Chemistry, IJMS, Molecules, Metabolites
Bioactive Compounds and Therapeutics: Molecular Aspects, Metabolic Profiles, and Omics Studies 2nd Edition
Topic Editors: Michele Costanzo, Giovanni N. Roviello, Armando CeveniniDeadline: 20 November 2025
Topic in
Antioxidants, BioChem, IJMS, Metabolites, Biomedicines
Functional Food and Anti-Inflammatory Function
Topic Editors: Marika Cordaro, Rosanna Di Paola, Roberta FuscoDeadline: 30 November 2025
Topic in
Animals, Antioxidants, Metabolites, Pets, Veterinary Sciences
Research on Companion Animal Nutrition
Topic Editors: Baichuan Deng, Lian Li, Yun JiDeadline: 31 December 2025

Conferences
Special Issues
Special Issue in
Metabolites
Effects of Micronutrients on Human Metabolism
Guest Editor: Lin XiaoDeadline: 15 September 2025
Special Issue in
Metabolites
Metabolic Profiling in Neurometabolisms
Guest Editor: Larissa Daniele BoberminDeadline: 15 September 2025
Special Issue in
Metabolites
Modulating Gut Microbiota and Host Interactions: The Role of Diet, Probiotics, and Circadian Rhythms
Guest Editors: Miri Park, Jeehwan ChoeDeadline: 20 September 2025
Special Issue in
Metabolites
Metabolomics in Chronic Disease
Guest Editor: Xiaoyu CheDeadline: 20 September 2025
Topical Collections
Topical Collection in
Metabolites
Natural Antioxidants to Food Preservation
Collection Editor: Jose Lorenzo Rodriguez
Topical Collection in
Metabolites
Feature Papers Related to Metabolomic Profiling Technology
Collection Editor: Thusitha Rupasinghe
Topical Collection in
Metabolites
Feature Papers in Assessing Environmental Health and Function
Collection Editor: David J. Beale
Topical Collection in
Metabolites
Metabolic Effects of Animal Growth Promoters
Collection Editor: Chi Chen